Etripamil nasal spray in patients with Paroxysmal Supraventricular Tachycardia. Etripamil nasal spray in patients with Paroxysmal
Drug Application (NDA) for etripamil nasal spray for the treatment of paroxysmal supraventricular tachycardia (PVST). Etripamil is an
A nasal spray containing the experimental drug etripamil can quickly treat an abnormally fast heart rhythm called supraventricular
Etripamil nasal spray has been found to be a safe self-treatment for paroxysmal supraventricular tachycardia without medical supervision.
NODE-301 – ETRIPAMIL NASAL SPRAY FOR ACUTE TERMINATION OF SPONTANEOUS EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (NODE-301 – etripamil
The purpose of this study is to evaluate the safety of etripamil nasal spray in patients with Paroxysmal Supraventricular Tachycardia (PSVT). Patients will be
Dive into the research topics of 'Etripamil nasal spray: an investigational agent for the rapid termination of paroxysmal supraventricular tachycardia (SVT)'.
CARDAMYST, the conditionally approved brand name for etripamil nasal spray, is well studied with a robust clinical trial program that
Cardamyst (etripamil) is a novel calcium channel blocker nasal spray in development for the treatment of paroxysmal supraventricular tachycardia and atrial
Comments